A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
Paul James Wood
Research Funding - Novartis
Robyn Strong
Research Funding - Novartis
Grant A. McArthur
Consultant or Advisory Role - Amgen (U); Bristol-Myers Squibb (U); GlaxoSmithKline (U); Millennium (U); Novartis (U); Roche/Genentech (U)
Research Funding - Millennium; Novartis; Pfizer
Michael Michael
No relevant relationships to disclose
Elizabeth Algar
Honoraria - Novartis
Research Funding - Novartis
Andrea Muscat
Research Funding - Novartis
Lin Rigby
Research Funding - Novartis
David M. Ashley
Research Funding - Novartis